Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-14
1995-05-23
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514341, 5483151, A61K 31415, C07D23366, C07D40906
Patent
active
054182506
ABSTRACT:
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
REFERENCES:
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 5185351 (1993-02-01), Finrelstein et al.
Berger, "Medicinal Chemistry", 2nd Ed., pp. 565-571, 600, 601 (1960).
Denrewalter et al, "Progress in Drug Research", vol. 10, pp. 510-512 (1966).
Finkelstein Joseph A.
Keenan Richard M.
Weinstock Joseph
Higel Floyd D.
Lentz Edward T.
McCarthy Mary E.
SmithKline Beecham Corporation
Venetianer Stephen
LandOfFree
Imidazolyl-alkenoic acids useful as angiotensin II receptor anta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl-alkenoic acids useful as angiotensin II receptor anta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl-alkenoic acids useful as angiotensin II receptor anta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2140715